Gene-Edited stem cells aim to tame HIV in small trial

NCT ID NCT02500849

Ongoing Disease control Sponsor: City of Hope Medical Center Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 24 times

Summary

This early-stage study tests whether a patient's own blood stem cells, modified to resist HIV, can be safely infused after a mild chemotherapy-like conditioning. The goal is to see if the modified cells can take hold and help control the virus without lifelong daily medication. The trial involves 12 HIV-positive adults with well-controlled virus and no other major health issues.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Circle CARE Center, LLC

Norwalk, Connecticut, 06850, United States
City of Hope Medical Center

Duarte, California, 91010, United States
Mills Clinical Research

Los Angeles, California, 90069, United States
Quest Clinical Research

San Francisco, California, 94115, United States
UCLA CARE Center

Los Angeles, California, 90035, United States

Conditions

Explore the condition pages connected to this study.

HIV